AJP - Endo Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 297: E812-E821, 2009. First published July 21, 2009; doi:10.1152/ajpendo.00053.2009
0193-1849/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures
Right arrow All Versions of this Article:
297/3/E812    most recent
00053.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Alberti, A.
Right arrow Articles by Charonis, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alberti, A.
Right arrow Articles by Charonis, A.

ERp46 is reduced by high glucose and regulates insulin content in pancreatic β-cells

Avra Alberti, Panagiotis Karamessinis, Michalis Peroulis, Katerina Kypreou, Panagiotis Kavvadas, Stamatis Pagakis, Panagiotis K. Politis, and Aristidis Charonis

Division of Histology, Center for Basic Research I, and Center for Experimental Surgery, Biomedical Research Foundation of the Academy of Athens, Athens, Greece

Submitted 27 January 2009 ; accepted in final form 20 July 2009

Our studies focus on ERp46, an endoplasmic reticulum (ER) component, and analyze its involvement in glucose toxicity and in insulin production. Differences in pancreatic β-TC-6 cell proteome under conditions of low vs. high glucose were examined by proteomic approaches, including two-dimensional gel electrophoresis, image analysis, and mass spectrometry. Among differentially expressed proteins, ERp46, a novel endoplasmic reticulum component, was examined further. The expression of ERp46 in pancreatic sections was analyzed by immunocytochemistry, and high glucose-induced alterations of expression were evaluated in cultured β-cells, in isolated pancreatic islets, and in the pancreas of db/db diabetic animals. Inhibition of ERp46 expression by siRNA was performed to study its role in insulin production, in secretion, and in ER stress. Proteomic analysis led to identification of 46 differentially expressed spots corresponding to 23 proteins. Since ERp46 is a novel protein with a possible crucial role in secretory cells, we further analyzed its role in β-cell function. ERp46 expression is reduced in high glucose concentration in β-TC-6 cells and in isolated murine islets. Further analysis revealed high expression of ERp46 in pancreatic islets compared with exocrine tissue. Interestingly, a marked decrease in ERp46 expression was found in the pancreatic islets of db/db mice. Most importantly, siRNA-mediated knockdown of ERp46 in cultured β-cells led to a significant decrease in the insulin content; however, no alterations in insulin mRNA levels were observed under these conditions. In addition, reduced expression of ERp46 by siRNA increased the expression of CHOP and peIF2a, indicating development of ER stress. We conclude that ERp46 may be an important component in the phenomenon of "glucose toxicity" involved in insulin production at the posttranslational level.

diabetes; glucose toxicity; proteomics; endoplasmic reticulum



Address for reprint requests and other correspondence: A. S. Charonis, Section of Histology, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 4, Soranou Efessiou St., Athens 115 27, Greece (e-mail: acharonis{at}bioacademy.gr)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.